|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01093 CSPC PHARMA
Nominal 
9.940 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 13,273,416 | -18.489% | 16,284,282 | 16,080,412 | 15,610,026 | 13,822,275 |
| Cost of Sales | (4,563,224) | -1.437% | (4,629,735) | (4,842,773) | (4,271,542) | (3,297,610) |
| Gross Profit | 8,710,192 | -25.264% | 11,654,547 | 11,237,639 | 11,338,484 | 10,524,665 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | 24,273 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (12,769) | -75.287% | (51,669) | (18,503) | 823 | 1,550 | |
| Profit / (Loss) before Taxation | 3,117,667 | -17.981% | 3,801,130 | 3,681,554 | 3,719,460 | 3,662,878 | |
| Taxation | (543,617) | -27.485% | (749,664) | (623,514) | (692,377) | (553,767) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (26,199) | -15.737% | (31,092) | (91,053) | (60,878) | (46,542) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,547,851 | -15.645% | 3,020,374 | 2,966,987 | 2,966,205 | 3,062,569 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (73,097) | -28.899% | (102,807) | (114,083) | (88,753) | (70,223) |
| Depreciation & Amortisation | 691,495 | 9.495% | 631,531 | 531,900 | 481,634 | 430,480 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 22.290 | -12.623% | 25.510 | 24.950 | 24.890 | 25.620 |
| DPS (cts) | 12.780 | -- | 14.648 | 12.858 | 8.715 | 6.653 |
| Dividend Payout Ratio (%) | 57.335% | -- | 57.423% | 51.536% | 35.015% | 25.967% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.887 | -- | 2.930 | 2.673 | 2.350 | 2.046 |
| Remarks: | Real time quote last updated: 22/09/2025 16:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,547,851 |
| %Change | -15.645% |
| EPS / (LPS) | RMB 0.223 |
| NBV Per Share (¥) | RMB 2.887 |